Comparing the Effectiveness and Safety of Intravenous Levetiracetam and Phenobarbital as First-Line Therapies for Neonatal Seizures: A Randomized Clinical Trial Levetiracetam and Phenobarbital as first-line therapies for neonatal seizures
Iranian Journal of Child Neurology,
Vol. 19 No. 2 (2025),
11 March 2025
,
Page 65-75
https://doi.org/10.22037/ijcn.v19i2.45234
Abstract
Objectives
This randomized clinical trial aims to evaluate and compare phenobarbital and levetiracetam effectiveness and safety in controlling neonatal seizures as first-line therapeutic options.
Materials & Methods
Neonates with seizure manifestations presenting to the Bahrami Hospital from March 2020 to March 2022 were enrolled in this study. Patients’ data were recorded, including demographic findings, anthropometric measurements, birth characteristics, and laboratory findings. Patients were randomly divided into the phenobarbital and levetiracetam treatment groups. Outcomes defined as adverse effects, response to medication, time to start enteral feeding, and length of hospital stay were compared between the two treatment groups.
Results
The current study comprises 44 neonates divided into phenobarbital and levetiracetam groups. Seizure control among the two groups was not significantly different, with levetiracetam and phenobarbital groups showing seizure control of 68.2% and 59.1%, respectively. Moreover, no significant difference was observed regarding the duration of hospitalization and time to initiate feeding. No adverse effect was reported in either group.
Conclusion
This study showed no significant difference between levetiracetam and phenobarbital for neonatal seizure control.
- Neonatal Seizure
- Phenobarbital
- Levetiracetam
How to Cite
References
Han JY, Moon CJ, Youn YA, Sung IK, Lee IG. Efficacy of levetiracetam for neonatal seizures in preterm infants. BMC Pediatr. 2018;18(1):131.
Liu BK, Jiang L, Li XJ, Hong SQ, Chen W, Hu Y. Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures. Int J Neurosci. 2020;130(4):336-42.
El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med. 2017;22(5):321-7.
Shellhaas R. Clinical features, evaluation, and diagnosis of neonatal seizures. UptoDate2022.
Mollamohammadi M, Amirhoseini ZS, Saadati A, Pirzadeh Z, Hassan Amouzadeh M. Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures. Iran J Child Neurol. 2018;12(4):103-10.
Kaushal S, Tamer Z, Opoku F, Forcelli PA. Anticonvulsant drug–induced cell death in the developing white matter of the rodent brain. Epilepsia. 2016;57(5):727-34.
Sharpe C, Reiner GE, Davis SL, Nespeca M, Gold JJ, Rasmussen M, et al. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020;145(6).
Karaoglu P, Hiz S, Işcan B, Polat A, Ayanoǧlu M, Duman N, et al. Intravenous levetiracetam for treatment of seizures in term and preterm neonates. J Pediatr Neurosci. 2020;15(1):15-20.
Harris ML, Malloy KM, Lawson SN, Rose RS, Buss WF, Mietzsch U. Standardized Treatment of Neonatal Status Epilepticus Improves Outcome. Journal of Child Neurology. 2016;31(14):1546-54.
Torrence C. Neonatal seizures: Part II. Recognition, treatment, and prognosis. Neonatal Network: NN. 1985;4(2):21-8.
Wagner CB, Kreimer AM, Carrillo NP, Autry E, Schadler A, Cook AM, et al. Levetiracetam Compared to Phenobarbital as a First Line Therapy for Neonatal Seizures: An Unexpected Influence of Benzodiazepines on Seizure Response. J Pediatr Pharmacol Ther. 2021;26(2):144-50.
Van Den Broek M, Groenendaal F, Toet M, Van Straaten H, Van Hasselt J, Huitema A, et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia. Clinical pharmacokinetics. 2012;51(10):671-9.
Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proceedings of the National Academy of Sciences. 2002;99(23):15089-94.
Mruk AL, Garlitz KL, Leung NR. Levetiracetam in neonatal seizures: a review. The Journal of Pediatric Pharmacology and Therapeutics. 2015;20(2):76-89.
Loiacono G, Masci M, Zaccara G, Verrotti A. The treatment of neonatal seizures: focus on Levetiracetam. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(1):69-74.
Piña‐Garza JE, Nordli Jr DR, Rating D, Yang H, Schiemann‐Delgado J, Duncan B, et al. Adjunctive levetiracetam in infants and young children with refractory partial‐onset seizures. Epilepsia. 2009;50(5):1141-9.
Grinspan ZM, Shellhaas RA, Coryell J, Sullivan JE, Wirrell EC, Mytinger JR, et al. Comparative effectiveness of levetiracetam vs phenobarbital for infantile epilepsy. JAMA Pediatrics. 2018;172(4):352-60.
Mbizvo GK, Dixon P, Hutton JL, Marson AG. Levetiracetam add‐on for drug‐resistant focal epilepsy: an updated Cochrane Review. Cochrane Database of Systematic Reviews. 2012(9).
Qiao MY, Cui HT, Zhao LZ, Miao JK, Chen QX. Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:747745.
Mohamad A. Mikati DT. Neonatal Seizures. Nelson Textbook of Pediatrics2019. p. 3111-6.
Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841-6.
Bragg. LVSMFHBN. APGAR Score 2023 [Available from: https://www.ncbi.nlm.nih.gov/books/NBK470569/.
Shellhaas R. Treatment of neonatal seizures. UptoDate2022.
Ghaffar J, Riaz A, Uzair, Virk AO, Bhatti A. Comparative efficacy of intravenous levetiracetam vs phenobarbitone in neonatal seizures. Med Forum Monthly. 2020;31(7):25-8.
Gowda VK, Romana A, Shivanna NH, Benakappa N, Benakappa A. Levetiracetam versus Phenobarbitone in Neonatal Seizures — A Randomized Controlled Trial. Indian Pediatr. 2019;56(8):643-6.
Kumar J, Meena J, Yadav J, Saini L. Efficacy and Safety of Phenobarbitone as First-Line Treatment for Neonatal Seizure: A Systematic Review and Meta-Analysis. J Trop Pediatr. 2021;67(1).
- Abstract Viewed: 104 times